Howard Liang, Ph.d.
CFO and Chief Strategy Officer
Management Department
Bei Gene
China
Biography
Former Managing Director and Head of Biotechnology Equity Research at Leerink Partners. Institutional Investor All-America Research Team, Biotechnology / Mid- & Small-Cap, 2015; Bloomberg Markets Top US Analysts in Biotechnology, 2012; Wall Street Journal “Best of the Street” in Biotechnology and Pharmaceuticals, 2010 and in Biotechnology, 2008.Senior biotechnology analyst at AG Edwards, JMP Securities; Associate Analyst at Prudential Securities covering major and specialty pharmaceuticals. Senior Scientist at Abbott Laboratories and member of industry’s leading structure-based drug design teams; authored review and 13 papers including six in Nature, Science, and Proceedings of National Academy of Sciences.M.B.A., and Ph.D. in Biochemistry and Molecular Biology from The University of ChicagoB.S. in Chemistry from Peking University
Research Interest
Biotechnology and Pharmaceuticals,structure-based drug design
